This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Cloxacillin Sodium for Injection 500mg
- Starting date:
- July 18, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-34919
Recalled products
- Cloxacillin Sodium for Injection 500mg
Reason
High out-of-specification test assay results at the 17-month time point.
Depth of distribution
Wholesalers, pharmacies, and hospitals across Canada.
Affected products
A. Cloxacillin Sodium for Injection 500mg
DIN, NPN, DIN-HIM
DIN 01912429
Dosage form
Powder for solution
Strength
- 500 mg / vial
Lot or serial number
- BN2418
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA